Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ENZN Relative to the S&P 500

ENZN Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Enzon, Inc. (OTCMKT:ENZN) seasonal charts above shows that a Buy Date of November 3 and a Sell Date of January 24 has resulted in a geometric average return of 5.59% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 26.89% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Enzon Pharmaceuticals, Inc. engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.

To download ENZN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ENZN